Small Cap Stock Analysis

Small-Cap JAZZ Pharma Jumps Over 50% in Price Gain on Phase III Trial Progress

JAZZ experimental pain disorder drug meets key Phase III goals.

Published: Thursday, June 25, 2009 @ 9:23 AM PDT
Rating N/A

We've covered this stock before, and recently I might add, and noted that it had significant investor potential because of its place in the pharmaceutical trail phase chains with a number of its products. Well the news today that its pain reduction medicine for fibromyalgia patients had cleared some late-stage approval tests sent the stock over a 50% gain picking up $1.65.

The stock now trades on the Nasdaq in the $5 range on today's news. Jazz Pharmaceuticals (JAZZ) http://www.jazzpharmaceuticals.com/ average daily 3-Month trading volume is 1,323,560 shares. Share volume today is nearly ten times that average. Though it will shift today, the best estimate at the time of this article is that Small-Cap JAZZ has a market cap of $142 million.

A TWO DAY CHART OF JAZZ

jazz chart

The late-stage study results confirm prior late-stage data for JZP-6, which contains the same active ingredient found in Xyrem. That drug is already approved as a sleep disorder treatment.

JAZZ will now ask the Food and Drug Administration to approve the drug as a fibromyalgia treatment by the end of 2009. Fibromyalgia is a pain disorder.

And for all of you that are new to this stock, JAZZ said preliminary data from a second late-stage trial of its experimental pain drug Xyrem, showed that the study met its main goal. JAZZ is a specialty pharmaceutical company that develops and commercializes products for neurology and psychiatry primarily in the United States.

JAZZ's primary products include Xyrem for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy; and Luvox CR for obsessive compulsive disorder and social anxiety disorder.

JAZZ has a 52-week high of $8.95 set on 06-25-08 and a 52-week low of $0.52 set on 04-22-09. At $5 is far, far beyond both its 50-day and 200-day moving average with trailing twelve month revenues of $$74.96 million. It shares out versus float ratio is a smidge lop-sided, but isn't of concern, although I would like to see a few more shares in the float.

Rate It : 1 2 3 4 5

 
Post A Comment
 
 
 
 
Search SCN
Bookmark and Share

Get the SCN
Newsletter Today!

Find out WHAT's Hot and What's Not from Top Traders and Investors.

Gain Insight into Which Small Cap Growth Stocks Have the Potential for Monster Returns.

Identify Market Trends and Changes Before the Rest of the Crowd.

Whitelist Us

Having Trouble Getting Our Email Newsletter?  Whitelist Us.

Click here for more info...

Fri, Mar 19, 2010 @ 10:39 AM PDT
Despite the fact that the market's pullback today is likely to bleed into next week (and perhaps longer, give the size of the recent runup), a handful of small caps - largely unknown to investors - are...
Rating N/A
Fri, Mar 12, 2010 @ 10:53 AM PST
Considering about half of a stock's individual performance relies on sector and industry influence rather than the company's merits, it makes sense to stay abreast of industry trends. With that in mind...
Rating N/A
Fri, Mar 05, 2010 @ 10:25 AM PST
Are there any sectors or industries of any market cap that have simply been overlooked by the bulls and the media over the last twelve months? Sure, and they're very undervalued as a result. We'll take...
Rating 5
Fri, Feb 26, 2010 @ 12:29 PM PST
It was a busy week on the economic announcement front. Lots of housing and real estate data, in particular, was spewed forth from the media machine without putting it all in its proper perspective. I want...
Rating N/A
Fri, Feb 19, 2010 @ 11:30 AM PST
Before anyone gets hysterical about looming interest rate increases, take a breath, and keep reading. While the news writers made something more than it as (as usual) in the case of yesterday's increase...
Rating N/A
SmallCap Network Newsletters

This community is currently in beta and is constantly undergoing active development.  Please be patient as we strive to bring you a usable, full-featured community that you will enjoy.  If you should have any questions, problems, suggestions, feature requests, rants, and/or raves, please do not hesitate to let us know by writing us as : webmaster@smallcapnetwork.com.